Get my own profile
Public access
View all36 articles
5 articles
available
not available
Based on funding mandates
Co-authors
- Andrew EwingUniversity of GothenburgVerified email at chem.gu.se
- Gary SiuzdakProfessor and Director, Center for Metabolomics, The Scripps Research InstituteVerified email at scripps.edu
- Julijana IvanisevicUniversity of LausanneVerified email at unil.ch
- Nicholas WinogradPenn State UniversityVerified email at psu.edu
- H. Paul BentonVicinitas TherapeuticsVerified email at vicinitas.com
- Caroline H. JohnsonAssociate Professor, Yale School of Public HealthVerified email at yale.edu
- Gary J. PattiProfessor, Washington UniversityVerified email at wustl.edu
- Paul D. PiehowskiPacific Northwest National LaboratoryVerified email at pnnl.gov
- Lisa MellanderPostdoc at Gothenburg UniversityVerified email at gu.se
- Howard E. GendelmanProfessor and Chair, Pharmacology & Experimental Neuroscience, University of Nebraska Medical CenterVerified email at unmc.edu
- Nhu TN PhanUniversity of GothenburgVerified email at chem.gu.se
- Harsha Gowda, Ph.D.MedGenome Inc.Verified email at medgenome.com
- Shalini AnderssonChief Scientist & Head of Oligonucleotide discovery, AstraZenecaVerified email at astrazeneca.com
- Ralf TautenhahnThermo Fisher ScientificVerified email at thermofisher.com
- MINGLIANG FANGProfessor, Fudan University, ChinaVerified email at ntu.edu.sg
- Johan DunevallSystem Engineer at Gyros Protein TechnologiesVerified email at gyrosproteintech.com
- Per MalmbergChalmers University of Technology, Chemical Imaging infrastructure CIIVerified email at chalmers.se
- Matthew W. FieldsMontana State UniversityVerified email at biofilm.montana.edu
- Raphaël TrouillonPolytechnique MontréalVerified email at polymtl.ca
- Howard FoxProfessor of Neurological Sciences, Dean of ResearchVerified email at unmc.edu
Follow
Michael E. Kurczy
AstraZeneca, NanoSIMS - Chemical Imaging Infrastructure CII
Verified email at astrazeneca.com